Psychiatric symptoms in Parkinson’s disease: A team approach to successful management
Current Psychiatry. 2002 September;01(09):23-35
September 1, 2002|Current Psychiatry
Author and Disclosure Information
How can you make sound treatment decisions when almost no evidence exists on the use of psychotropics in patients with Parkinson’s disease? A psychiatrist and a neurologist argue that collaboration is key to treating PD patients’ psychiatric symptoms.
Drug brand names
- Alprazolam • Xanax
- Amantadine • Symmetrel
- Benztropine • Cogentin
- Biperiden • Akineton
- Buspirone • Buspar
- Carbidopa-levodopa • Sinemet
- Citalopram • Celexa
- Clozapine • Clozaril
- Entacapone • Comtan
- Fluvoxamine • Luvox
- Hyoscyamine • Levsin
- Paroxetine • Paxil
- Pergolide • Permax
- Pramipexole • Mirapex
- Ropinirole • Requip
- Selegeline • Eldepryl
- Sertraline • Zoloft
- Tolcapone • Tasmar
- Trihexyphenidyl • Artane
- Trifluoperazine • Stelazine
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
